State WI
Clinical Trials in Wisconsin
Recruiting clinical trials with at least one study location in Wisconsin. Data updated daily from ClinicalTrials.gov.
Top Conditions in Wisconsin
Breast Cancer (6)Stage IVB Prostate Cancer AJCC v8 (4)Chronic Lymphocytic Leukemia (4)Stroke (3)Small Lymphocytic Lymphoma (3)Asthma (3)Cardiovascular Diseases (3)Castration-Resistant Prostate Carcinoma (3)Prostate Cancer (3)PTSD (2)Oral Cavity Squamous Cell Carcinoma (2)Stage I Lip and Oral Cavity Cancer AJCC v8 (2)
Frequently Asked Questions — Clinical Trials in Wisconsin
How many clinical trials are currently recruiting in Wisconsin?
ClinicalMetric currently tracks 186 actively recruiting clinical trials with at least one location in Wisconsin. The total number of registered studies—including active but not currently enrolling trials—is 186. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Wisconsin?
Wisconsin hosts clinical trials across a broad range of medical conditions, including Breast Cancer, Stage IVB Prostate Cancer AJCC v8, Chronic Lymphocytic Leukemia, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Wisconsin serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Wisconsin?
To join a clinical trial in Wisconsin, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Wisconsin maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.
Recruiting Trials in Wisconsin
NCT07215624 N/A
Recruiting
Surgical Thromboprophylaxis Practices in Oncology Patients Within the NCORP Netw...
Condition
Malignant Digestive System Neoplasm
Enrollment
500 pts
Location
United States, Puerto Rico
Sponsor
Wake Forest University Health
NCT06975046 N/A
Recruiting
Aerodynamic Measurements in the Pediatric Population
Condition
Normal Voice
Enrollment
365 pts
Location
United States
Sponsor
University of Wisconsin, Madis
NCT06110897 N/A
Recruiting
RESISTance Exercise for Depression Trial
Condition
Major Depressive Disorder
Enrollment
200 pts
Location
United States
Sponsor
University of Wisconsin, Madis
NCT04079179 Phase 2
Recruiting
Cobimetinib in Refractory Langerhans Cell Histiocytosis (LCH), and Other Histioc...
Condition
Langerhan's Cell Histiocytosis
Enrollment
90 pts
Location
United States
Sponsor
Carl Allen
NCT05303519 Phase 3
Recruiting
SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
Condition
Glioma
Enrollment
365 pts
Location
United States, Australia, China
Sponsor
Nuvation Bio Inc.
NCT06361940 Phase 2
Recruiting
Molecular Analyses to Predict Pathways of Endocrine Resistance Following Short T...
Condition
Breast Cancer
Enrollment
100 pts
Location
United States
Sponsor
Medical College of Wisconsin
NCT06305715 Phase 2
Recruiting
Radiation Prior to TKI to Delay Progression in Advanced Driver-Mutated Non-small...
Condition
Non Small Cell Lung Cancer
Enrollment
34 pts
Location
United States
Sponsor
Medical College of Wisconsin
NCT06931340 Phase 3
Recruiting
Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormona...
Condition
Castration-Sensitive Prostate Carcinoma
Enrollment
1,260 pts
Location
United States
Sponsor
Alliance for Clinical Trials i
NCT05365581 Phase 1
Recruiting
A Study of ASP2138 Given by Itself or Given With Other Cancer Treatments in Adul...
Condition
Gastric Adenocarcinoma
Enrollment
398 pts
Location
United States, China, France
Sponsor
Astellas Pharma Global Develop
NCT04269902 Phase 3
Recruiting
Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia...
Condition
Chronic Lymphocytic Leukemia
Enrollment
247 pts
Location
United States, Canada
Sponsor
National Cancer Institute (NCI
NCT04174157 N/A
Recruiting
Registry of Patients With a Diagnosis of Spinal Muscular Atrophy (SMA)
Condition
Spinal Muscular Atrophy (SMA)
Enrollment
700 pts
Location
United States, Greece, Ireland
Sponsor
Novartis Pharmaceuticals
NCT05444465 N/A
Recruiting
Use of the REGENETEN™ Bioinductive Implant System in High Grade Partial-thicknes...
Condition
Rotator Cuff Injuries
Enrollment
234 pts
Location
United States, Australia, Canada
Sponsor
Smith & Nephew, Inc.
NCT05223322 N/A
Recruiting
Understanding and Addressing Disparities in Cancer Therapy Induced Inflammation ...
Condition
Breast Cancer
Enrollment
80 pts
Location
United States
Sponsor
Medical College of Wisconsin
NCT06649812 Phase 2
Recruiting
Testing the Effectiveness of a Combination Targeted Therapy (ViPOR) for Patients...
Condition
High Grade B-Cell Lymphoma With MYC and BCL6 Rearrangements
Enrollment
120 pts
Location
United States
Sponsor
National Cancer Institute (NCI
NCT05603728 N/A
Recruiting
Exactech Shoulder Post Market Clinical Follow-up Study
Condition
Osteo Arthritis Shoulders
Enrollment
20,000 pts
Location
United States, Canada, France
Sponsor
Exactech
NCT04375722 N/A
Recruiting
Transcranial Alternating Current Stimulation (tACS) in Aphasia
Condition
Aphasia
Enrollment
50 pts
Location
United States
Sponsor
Medical College of Wisconsin
NCT06685757 Phase 3
Recruiting
A Study to Learn More About the Effects and Safety of Felzartamab Infusions in A...
Condition
Antibody-mediated Rejection
Enrollment
120 pts
Location
United States, Argentina, Australia
Sponsor
Biogen
NCT06690801 N/A
Recruiting
Dead Space and Inhaled Nitric Oxide in Pediatric Acute Respiratory Distress Synd...
Condition
Acute Respiratory Distress Syndrome
Enrollment
1,260 pts
Location
United States
Sponsor
Children's Hospital Los Angele
NCT06658730 N/A
Recruiting
Long-term Characterization of GORE® TAG® Conformable Thoracic Stent Graft With A...
Condition
Vascular Disease
Enrollment
1,500 pts
Location
United States, Denmark, France
Sponsor
W.L.Gore & Associates
NCT06966375 N/A
Recruiting
Worldwide Yearly Screening for Hypospadias
Condition
Hypospadias
Enrollment
20 pts
Location
United States
Sponsor
University of Wisconsin, Madis
NCT05904028 Phase 3
Recruiting
Home OCT-Guided Treatment Versus Treat and Extend for the Management of Neovascu...
Condition
Neovascular Age-related Macular Degeneration
Enrollment
600 pts
Location
United States, Canada
Sponsor
Jaeb Center for Health Researc
NCT07308236 Phase 1
Recruiting
A Study to Determine the Metabolism and Excretion of [14C]E2086 in Healthy Male ...
Condition
Healthy Volunteers
Enrollment
10 pts
Location
United States
Sponsor
Eisai Inc.
NCT07000357 Phase 3
Recruiting
A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a Histo...
Condition
Cardiovascular Disease
Enrollment
15,100 pts
Location
United States, Argentina, Brazil
Sponsor
AstraZeneca
NCT06052267 Phase 3
Recruiting
A Study to Test if a Fixed-Dose Combination of Fluticasone Propionate/Albuterol ...
Condition
Asthma
Enrollment
2,700 pts
Location
United States, Argentina, Australia
Sponsor
Teva Branded Pharmaceutical Pr
NCT06526195 N/A
Recruiting
Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in ...
Condition
Heart Failure
Enrollment
850 pts
Location
United States, Austria, Czechia
Sponsor
Abbott Medical Devices
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology